Diabetic cardiomyopathy (DCM) is the leading cause of mortality in diabetes. As the number of cases of diabetes continues to rise, it is urgent to develop new strategies to protect against DCM, which is characterized by cardiac hypertrophy, increased apoptosis, fibrosis, and altered insulin metabolism. The E3 ubiquitin ligases (E3s), one component of the ubiquitin-proteasome system, play vital roles in all of the features of DCM listed above. They also modulate the activity of several transcription factors involved in the pathogenesis of DCM. In addition, the E3s degrade both insulin receptor and insulin receptor substrates and also regulate insulin gene transcription, leading to insulin resistance and insulin deficiency. Therefore, the E3s may be a driving force for DCM. This review summarizes currently available studies to analyze the roles of the E3s in DCM, enriches our knowledge of how DCM develops, and provides a novel strategy to protect heart from diabetes.
[1]Jilin Univ, Hosp 1, Ctr Cardiovasc, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.
[2]Peoples Hosp Jilin Prov, Internal Med, Changchun, Peoples R China.
[3]Univ Louisville, Dept Pediat, Kosair Childrens Hosp, Res Inst, Louisville, KY 40292 USA.
[4]Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA.
(8.0+极速模式)